Evolution and Clinical Significance of the T Cell Proliferative and Cytokine Response Directed Against the Fibronectin Binding Antigen 85 Complex of Bacillus Calmette-Guerin During Intravesical Treatment of Superficial Bladder Cancer

Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

1983 • 1,918 citations

p53 Status and the Efficacy of Cancer Therapy in Vivo

1994 • 1,483 citations

Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer

1992 • 756 citations

LONG-TERM RESULTS OF INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCER

1992 • 285 citations

T-Cell Subsets Required for Intravesical BCG Immunotherapy for Bladder Cancer

1993 • 278 citations

Effects of Local Bacillus Calmette-Guerin Therapy in Patients with Bladder Carcinoma on Immunocompetent Cells of the Bladder Wall

1990 • 216 citations

Elevations of Cytokines Interleukin-1, Interleukin-2 and Tumor Necrosis Factor in the Urine of Patients after Intravesical Bacillus Calmette-Guerin Immunotherapy

1990 • 202 citations

The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis.

1992 • 190 citations

Urinary Cytokines During Intravesical Bacillus Calmetteguerin Therapy for Superficial Bladder Cancer: Processing, Stability and Prognostic Value

1996 • 185 citations

Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response.

1990 • 184 citations

Specific Lymphoproliferation, Gamma Interferon Production, and Serum Immunoglobulin G Directed against a Purified 32 kDa Mycobacterial Protein Antigen (P32) in Patients with Active Tuberculosis

1988 • 181 citations

Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice

1992 • 171 citations

Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: Effect of Bacillus Calmette-Guerin Viability on Treatment Results

1985 • 150 citations

T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy

1994 • 149 citations

The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis

1991 • 125 citations

Durability of the Tumor-Free Response for Intravesical Bacillus Calmette-Guerin Therapy

1994 • 114 citations

Immunity to mycobacteria

1993 • 106 citations

BCG in Perspective: Advances in the Treatment of Superficial Bladder Cancer

1995 • 69 citations

The induction of bacillus-Calmette-Gu�rin-activated killer cells requires the presence of monocytes and T-helper type-1 cells

1995 • 59 citations

Limited clonal heterogeneity of antigen-specific T cells localizing in the pleural space during mycobacterial infection

1991 • 47 citations

The Effects of Recombinant Human Intereron-Gamma on a Panel of Human Bladder Cancer Cell Lines

1991 • 41 citations

Fibronectin Expression on Surgical Specimens Correlated with the Response to Intravesical Bacillus Calmette-Guerin Therapy

1993 • 24 citations

The Major Secreted Antigen Complex (Ag 85) from Mycobacterium bovis Bacille Calmette-Guerin Is Associated with Protective T Cells in Leprosy: A Follow-Up Study of 45 Household Contacts

1993 • 21 citations

Prognostic Significance of Circulating Cytotoxic Lymphocytes Against Autologous Tumors in Patients With Bladder Cancer

1996 • 19 citations

BIOCHEMISTRY OF BLADDER CANCER INVASION AND METASTASIS

1992 • 16 citations

Peripheral Blood Lymphocyte Response in Patients with Superficial Transitional Cell Carcinoma of the Bladder Treated with Intravesical Bacillus Calmette‐Guérin—A Useful Marker of Response?

1993 • 13 citations